Vera Therapeutics (VERA) Amortizatization of Intangibles (2022 - 2026)
Vera Therapeutics posted quarterly Amortizatization of Intangibles of $116000.0 for Q1 2026, down 74.62% year-on-year from $457000.0 in Q1 2025, and up 2.65% on a QoQ basis from $113000.0 in Q4 2025.
Vera Therapeutics (VERA) has 5 years of Amortizatization of Intangibles data on file, last reported at $116000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 74.62% year-over-year to $116000.0; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (down 44.71% YoY), and the FY2025 full-year result was $1.4 million, down 29.8% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $116000.0, up from $113000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $595000.0 in Q4 2022 and bottomed at $113000.0 in Q4 2025.
- The 5-year median for Amortizatization of Intangibles is $532000.0 (2023), against an average of $477882.4.
- The widest annual swing landed in 2024, when Amortizatization of Intangibles grew 3.01%; it then tumbled 79.38% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $595000.0 in 2022, then retreated by 10.59% to $532000.0 in 2023, then advanced by 3.01% to $548000.0 in 2024, then sank by 79.38% to $113000.0 in 2025, then grew by 2.65% to $116000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $116000.0 (Q1 2026), $113000.0 (Q4 2025), and $435000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - | 116,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116,000.00 |
| Mar 31, 2026 | 116,000.00 |
| Dec 31, 2025 | 113,000.00 |
| Dec 31, 2025 | 113,000.00 |
| Sep 30, 2025 | 435,000.00 |
| Sep 30, 2025 | 435,000.00 |
| Jun 30, 2025 | 444,000.00 |
| Jun 30, 2025 | 444,000.00 |
| Mar 31, 2025 | 457,000.00 |
| Mar 31, 2025 | 457,000.00 |
| Dec 31, 2024 | 548,000.00 |
| Dec 31, 2024 | 548,000.00 |
| Sep 30, 2024 | 496,000.00 |
| Sep 30, 2024 | 496,000.00 |
| Jun 30, 2024 | 503,000.00 |
| Jun 30, 2024 | 503,000.00 |
| Mar 31, 2024 | 517,000.00 |
| Mar 31, 2024 | 517,000.00 |
| Dec 31, 2023 | 532,000.00 |
| Dec 31, 2023 | 532,000.00 |
| Sep 30, 2023 | 549,000.00 |
| Sep 30, 2023 | 549,000.00 |
| Jun 30, 2023 | 564,000.00 |
| Jun 30, 2023 | 564,000.00 |
| Mar 31, 2023 | 579,000.00 |
| Mar 31, 2023 | 579,000.00 |
| Dec 31, 2022 | 595,000.00 |
| Dec 31, 2022 | 595,000.00 |
| Sep 30, 2022 | 561,000.00 |
| Sep 30, 2022 | 561,000.00 |
| Jun 30, 2022 | 551,000.00 |
| Jun 30, 2022 | 551,000.00 |
| Mar 31, 2022 | 564,000.00 |
| Mar 31, 2022 | 564,000.00 |